DavidHLawsonMD

Oncology • Atlanta, GA

Hematologic Oncology, Melanoma

Professor of Hematology & Oncology, Emory University

Join to view full profile

Dr. Lawson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lawson's full profile

Already have an account?

Office
1365 Clifton Rd NE
Atlanta, GA 30322
Phone+1 404-778-1900

Education & Training

Emory University School of MedicineFellowship, Hematology and Medical Oncology, 1977 - 1979
Emory University School of MedicineResidency, Internal Medicine, 1974 - 1977
Emory University School of MedicineClass of 1974

Certifications & Licensure

GA State Medical License 1975 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
Atlanta Magazine: Top Doctors Castle Connolly, 2005, 2007, 2009-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

A Randomized, Placebo-Controlled Phase III Trial of Yeast Derived GM-CSF Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With "No Evidence of Disease" After Complete Surgical Resection of "Locally Advanced" and Start of enrollment: 1999 Dec 01
FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma Start of enrollment: 2005 Oct 04
Terminated
Phase 2
Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment Start of enrollment: 2006 Oct 06
Completed
Phase 4
Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2011 Jan 18
Completed
Phase 2
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy Start of enrollment: 2011 Aug 01
Completed
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma Start of enrollment: 2012 Aug 01
Terminated
Phase 4
Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2014 Jan 24
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Cutaneous and Noncutaneous Adverse Effects in Patients with Advanced Melanoma Receiving Immunotherapy.
Howa Yeung, Krittin J Supapannachart, Sandy Francois, Colin H Adler, Ragini R Kudchadkar
JID Innovations. 2023-11-01
Metastatic Melanoma Treatment with Pembrolizumab after Hypersensitivity Reaction to Nivolumab: A Case Report.
Alyssa R Cruse, Alexa J Basilio, David H Lawson
Case Reports in Oncology. 2023-10-26
16 citations
Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing.
Mohammed Kashani-Sabet, Sancy A Leachman, Jennifer A Stein, Jack L Arbiser, Elizabeth G Berry
JAMA Dermatology. 2023-05-01

Journal Articles

Prognostic Gene Expression Profiling in Cutaneous Melanoma
Douglas Grossman, Sancy A Leachman, Larissa Korde, Elizabeth I Buchbinder, Emily Y Chu, Julia A Curtis, Laura K Ferris, Kenneth F Grossmann, Siwen Hu-Lieskovan, Joanne..., JAMA Dermatology
T Cell Receptor Sequencing of Activated CD8 T Cells in the Blood Identifies Tumor-Infiltrating Clones That Expand After PD-1 Therapy and Radiation in a Melanoma Patient
Jonathan J Masor, Juan Sarmiento, Walter J Curran, David H Lawson, Rafi Ahmed, Yue Xue, Cancer Immunology, Immunotherapy

Authored Content

Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020

Press Mentions

Cancer Spread to Jimmy Carter's Brain 9 Years Ago. Here's How He's Lived so LongSeptember 30th, 2024
Cancer Treatment Extended Jimmy Carter’s Life Before His 100th BirthdaySeptember 30th, 2024
Gift Honoring David Lawson, MD, Endows Cancer Research Professorship at WinshipFebruary 4th, 2022

Grant Support

Radioimmunoassay In The Evaluation Of Response To Hypophysectomy In MelanomaNational Center For Research Resources1985
Pharmacokinetics And Toxicity Of High Dose Methotrexate With Leucovorin RescueNational Center For Research Resources1985

Professional Memberships

American Society of Clinical Oncology - ASCO
Member